Navellier & Associates’s NeoGenomics NEO Stock Holding History

Navellier & Associates’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,802	Closed	-$232K	–	342
2021 Q3	$232K	Buy	+4,802	New	+$222K	0.04%	284

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Navellier & Associates's NEO Position: Q4 2021 in Review

Navellier & Associates sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 4,802 shares — an estimated $232K sold.

Navellier & Associates first reported a position in NEO in Q3 2021 and held it in 1 quarter. The position peaked at $232K in Q3 2021. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

Navellier & Associates reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
Navellier & Associates sold 4,802 NeoGenomics shares in Q4 2021, an estimated $232K.
Navellier & Associates first reported a position in NeoGenomics in Q3 2021 and held it in 1 quarter.
Navellier & Associates's NeoGenomics position peaked at $232K in Q3 2021.
307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Navellier & Associates's 13F filing for Q4 2021, filed 14 Feb 2022.